Agilent Technologies (A) and Danaher (DHR) screen as potential buyers of Qiagen (QGEN) after a report that the European molecular testing firm is weighing its options after takeover interest. "QGEN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results